CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2022-11, Vol.24 (Supplement_7), p.vii84-vii84
Main Authors: Wright, Karen, Kline, Cassie, Abdelbaki, Mohamed, Ebb, David, Sayour, Elias, Elster, Jennifer, Leary, Sarah, Miller, Matthew, Margol, Ashley, Cohen, Kenneth, Kilburn, Lindsay, Bendel, Anne, Kao, Pei-Chi, Ma, Clement, London, Wendy, Mueller, Sabine, Prados, Michael, Haas-Kogan, Daphne
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/noac209.318